Tenaya Therapeutics, Inc. (TNYA)
0.6687
-0.03
(-4.10%)
USD |
NASDAQ |
Aug 24, 16:00
0.6687
0.00 (0.00%)
After-Hours: 20:00
Tenaya Therapeutics Market Cap : 149.94M for Aug. 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 21, 2026 | 156.36M |
| August 20, 2026 | 154.83M |
| August 19, 2026 | 159.85M |
| August 18, 2026 | 156.62M |
| August 17, 2026 | 156.98M |
| August 14, 2026 | 163.26M |
| August 13, 2026 | 164.36M |
| August 12, 2026 | 171.20M |
| August 11, 2026 | 168.46M |
| August 10, 2026 | 165.35M |
| August 07, 2026 | 162.97M |
| August 06, 2026 | 162.75M |
| August 05, 2026 | 175.95M |
| August 04, 2026 | 166.29M |
| August 03, 2026 | 163.46M |
| July 31, 2026 | 160.64M |
| July 30, 2026 | 162.75M |
| July 29, 2026 | 159.52M |
| July 28, 2026 | 164.07M |
| July 27, 2026 | 167.00M |
| July 24, 2026 | 168.17M |
| July 23, 2026 | 167.76M |
| July 22, 2026 | 171.21M |
| July 21, 2026 | 178.94M |
| July 20, 2026 | 177.55M |
| Date | Value |
|---|---|
| July 17, 2026 | 177.29M |
| July 16, 2026 | 181.76M |
| July 15, 2026 | 182.97M |
| July 14, 2026 | 187.62M |
| July 13, 2026 | 181.52M |
| July 10, 2026 | 188.88M |
| July 09, 2026 | 184.45M |
| July 08, 2026 | 190.94M |
| July 07, 2026 | 199.64M |
| July 06, 2026 | 187.79M |
| July 02, 2026 | 170.76M |
| July 01, 2026 | 161.86M |
| June 30, 2026 | 160.38M |
| June 29, 2026 | 159.47M |
| June 26, 2026 | 155.70M |
| June 25, 2026 | 154.07M |
| June 24, 2026 | 158.60M |
| June 23, 2026 | 157.54M |
| June 22, 2026 | 151.90M |
| June 18, 2026 | 158.54M |
| June 17, 2026 | 154.39M |
| June 16, 2026 | 147.56M |
| June 15, 2026 | 155.96M |
| June 12, 2026 | 154.46M |
| June 11, 2026 | 156.20M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Intellia Therapeutics, Inc. | 1.757B |
| Anavex Life Sciences Corp. | 287.75M |
| Arrowhead Pharmaceuticals, Inc. | 12.24B |
| Oncolytics Biotech, Inc. | 105.94M |
| Sangamo Therapeutics, Inc. | 58.95M |
Market Cap Related Metrics
| PS Ratio | 96.78 |
| Price to Book Value | 2.160 |
| Price | 0.6687 |
| Earnings Yield | -78.90% |